Document Server@UHasselt >
Research publications >
Please use this identifier to cite or link to this item:
|Title: ||How to carry out a field walking test in chronic respiratory disease|
|Authors: ||Holland, Anne E.|
Spruit, Martijn A.
Singh, Sally J.
|Issue Date: ||2015|
|Publisher: ||MANEY PUBLISHING|
|Citation: ||BREATHE, 11 (2), p. 129-139|
|Abstract: ||The European Respiratory Society (ERS) and American Thoracic Society (ATS) have recently published a Technical Standard which documents the standard operating procedures for the 6-min walk test (6MWT), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT). The Technical Standard shows that all three tests are valid and reliable measures of functional exercise capacity in people with chronic respiratory disease and makes recommendations for standardising their performance. Key findings and recommendations of the Technical Standard include: The 6MWT, ISWT and ESWT are strenuous tests which elicit cardiorespiratory responses that are similar to those observed during a maximal incremental exercise test. As a result, the contraindications and precautions for field walking tests should be consistent with those used for a laboratory-based incremental exercise test. There is strong evidence of a learning effect for the 6MWT and ISWT. Two tests should be performed when the 6MWT or ISWT are used to measure change over time. The 6MWT, ISWT and ESWT are responsive to treatment effects in people with chronic respiratory disease, particularly for rehabilitation... The 6MWT is very sensitive to variations in methodology, including use of encouragement, provision of supplemental oxygen, changes in track layout and length, and use of wheeled walkers. These factors should be documented and held constant on repeat testing. The lowest SpO(2)-recorded during a 6MWT is an important marker of disease severity and prognosis. Continuous pulse oximetry is recommended during the 6MWT, to ensure that the lowest SpO(2) is recorded. In adults with chronic respiratory disease, a change in 6-min walk distance of 30 m or more indicates a clinically significant change has occurred.|
|Notes: ||[Holland, Anne E.] La Trobe Univ, Dept Physiotherapy, Melbourne, Vic 3004, Australia. [Holland, Anne E.] Alfred Hlth, Dept Physiotherapy, Melbourne, Vic, Australia. [Holland, Anne E.] Austin Hlth, Inst Breathing & Sleep, Melbourne, Vic, Australia. [Spruit, Martijn A.] CIRO Ctr Expertise Chron Organ Failure, Dept Res & Educ, Horn, Netherlands. [Spruit, Martijn A.] Hasselt Univ, Fac Med & Life Sci, BIOMED Biomed Res Inst, REVAL Rehabil Res Ctr, Diepenbeek, Belgium. [Singh, Sally J.] Univ Hosp Leicester NHS Trust, Ctr Exercise & Rehabil Sci, Leicester, Leics, England. [Singh, Sally J.] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England.|
|ISI #: ||000366390800004|
|Type: ||Journal Contribution|
|Validation: ||vabb, 2018|
|Appears in Collections: ||Research publications|
Files in This Item:
|published version||664.71 kB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.